ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

101–120 of 216 studies

Illness beliefs and treatment outcome in chronic fatigue syndrome.

Deale, A, Chalder, T, Wessely, S·Journal of psychosomatic research·1998

This study examined whether what ME/CFS patients believe about the cause of their illness affects how well they recover with treatment. Researchers found that patients' beliefs about whether their condition was physical didn't predict treatment success. However, patients who changed their views about avoiding exercise and activity—and actually started doing more—improved more with cognitive-behavior therapy than with relaxation alone.

Evidence Atlas

Evidence browser

Illness beliefs and treatment outcome in chronic fatigue syndrome.

Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.

Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome.

Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluation.

Hyperbaric oxygen therapy improves clinical symptoms and functional capacity and modulates thalamic connectivity in ME/CFS: a prospective cohort study.

Association of rapamycin treatment with the modulation of purine metabolism, reduced microglial inflammatory responses, improved mitochondrial energy metabolism, and alleviation of fatigue symptoms in ME/CFS subjects: pilot findings from phase-II observational study.

Association between light exposure patterns and multidimensional health outcomes in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: findings from an observational cross-sectional cohort study.

Use and Perceived Helpfulness of Different Intervention Strategies in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Depression.

Testing a Personalised Dysautonomia Management Protocol in Patients with Orthostatic Intolerance and a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome or Long COVID.

Medication use and symptomology in North American women with myalgic encephalomyelitis/chronic fatigue syndrome.

Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study.

Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey.

The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome.

Robuvit® reduces fatigue after chemotherapy for colon cancer. A pilot registry study.

Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study.

Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole.

Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK.

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.

The Relationship Between Childhood Trauma and the Response to Group Cognitive-Behavioural Therapy for Chronic Fatigue Syndrome.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research